Hutchison China Meditech Limited Vesting of LTIP awards (8508A)
29 March 2017 - 6:07PM
UK Regulatory
TIDMHCM
RNS Number : 8508A
Hutchison China Meditech Limited
29 March 2017
Vesting of awards under the Long Term Incentive Plan
London: Wednesday, March 29, 2017: Hutchison China MediTech
Limited ("Chi-Med") (AIM/Nasdaq: HCM) announces that following the
publication of the 2016 annual report of Chi-Med on March 27, 2017,
the following awards granted under the Long Term Incentive Plan
("LTIP") on October 19, 2015 in respect of the annual performance
targets for the financial year 2014 to Mr. Christian Hogg, Mr.
Johnny Cheng and Dr. Weiguo Su were vested on March 28, 2017:-
Award Holders Number of Number of
Ordinary American depositary
Shares shares ("ADS")
Person Discharging Managerial
Responsibilities
Mr. Christian Hogg (Executive
Director and Chief Executive
Officer) 5,620 3,756
Mr. Johnny Cheng (Executive
Director and Chief Financial
Officer) Nil 4,626
Dr. Weiguo Su (Executive
Director and Chief Scientific
Officer) Nil 5,476
Total 5,620 13,858
========== =====================
The notifications set out below are provided in accordance with
the requirements of the EU Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely associated
----- ---------------------------------------------------------------------------------------------------------------
a) Name Mr Christian Hogg
----- ------------------------------------------------------- ------------------------------------------------------
2 Reason for the notification
----- ---------------------------------------------------------------------------------------------------------------
a) Position/status Executive Director and Chief Executive Officer
----- ------------------------------------------------------- ------------------------------------------------------
b) Initial notification/Amendment Initial notification
----- ------------------------------------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
----- ---------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
----- ------------------------------------------------------- ------------------------------------------------------
b) LEI N/A
----- ------------------------------------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
----- ---------------------------------------------------------------------------------------------------------------
Description of the financial instrument, type of Ordinary Shares of US$1.00 each
a) instrument ADS each representing one half of one Ordinary Share
Identification code of US$1.00
DI ISIN: KYG4672N1016
ADS ISIN: US44842L1035
----- ------------------------------------------------------- ------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on October 19, 2015 in
respect of the annual performance targets
for the financial year 2014 under Chi-Med's LTIP
----- ------------------------------------------------------- ------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------------------
Nil 5,620 Ordinary Shares
--------- ----------------------
Nil 3,756 ADS
--------- ----------------------
----- ------------------------------------------------------- ------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
----- ------------------------------------------------------- ------------------------------------------------------
e) Date of the transaction 2017-03-28
----- ------------------------------------------------------- ------------------------------------------------------
f) Place of the transaction London Stock Exchange (XLON) / Nasdaq Stock Market
----- ------------------------------------------------------- ------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Mr Johnny Cheng
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
a) Position/status Executive Director and Chief Financial Officer
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of ADS each representing one half of one Ordinary Share
instrument of US$1.00
Identification code ADS ISIN: US44842L1035
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on October 19, 2015 in
respect of the annual performance targets
for the financial year 2014 under Chi Med's LTIP
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
Nil 4,626 ADS
--------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 2017-03-28
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Dr Weiguo Su
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
a) Position/status Executive Director and Chief Scientific Officer
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Hutchison China MediTech Limited
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of ADS each representing one half of one Ordinary Share
instrument of US$1.00
Identification code ADS ISIN: US44842L1035
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Vesting of awards granted on October 19, 2015 in
respect of the annual performance targets
for the financial year 2014 under Chi-Med's LTIP
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
--------- ----------
Nil 5,476 ADS
--------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 2017-03-28
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction Nasdaq Stock Market
---- ------------------------------------------------------- -------------------------------------------------------
About Chi-Med
Chi-Med is an innovative biopharmaceutical company which
researches, develops, manufactures and sells pharmaceuticals and
healthcare products. Its Innovation Platform, Hutchison MediPharma
Limited, focuses on discovering and developing innovative
therapeutics in oncology and autoimmune diseases for the global
market. Its Commercial Platform manufactures, markets, and
distributes prescription drugs and consumer health products in
China.
Chi-Med is majority owned by the multinational conglomerate CK
Hutchison Holdings Limited (SEHK: 0001). For more information,
please visit: www.chi-med.com.
Forward Looking Statements
This announcement contains forward-looking statements within the
meaning of the "safe harbor" provisions of the U.S. Private
Securities Litigation Reform Act of 1995. Forward-looking
statements involve risks and uncertainties. Existing and
prospective investors are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
hereof. For further discussion of these and other risks, see
Chi-Med's filings with the U.S. Securities and Exchange Commission
and on AIM. Chi-Med undertakes no obligation to update or revise
the information contained in this announcement, whether as a result
of new information, future events or circumstances or
otherwise.
Contacts
Investor Enquiries
Christian Hogg, CEO +852 2121 8200
U.K. and International Media Enquiries
Anthony Carlisle, Citigate Dewe Rogerson +44 7973 611 888 (Mobile) anthony.carlisle@cdrconsultancy.co.uk
U.S. Based Media Enquiries
Brad Miles, BMC Communications +1 (917) 570 7340 (Mobile) bmiles@bmccommunications.com
Susan Duffy, BMC Communications +1 (917) 499 8887 (Mobile) sduffy@bmccommunications.com
Investor Relations
Matt Beck, The Trout Group +1 (917) 415 1750 (Mobile) mbeck@troutgroup.com
David Dible, Citigate Dewe Rogerson +44 7967 566 919 (Mobile) david.dible@citigatedr.co.uk
Panmure Gordon (UK) Limited
Richard Gray / Andrew Potts +44 (20) 7886 2500
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHOKCDPABKKQNB
(END) Dow Jones Newswires
March 29, 2017 03:07 ET (07:07 GMT)
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From Apr 2024 to May 2024
Hutchmed (china) (LSE:HCM)
Historical Stock Chart
From May 2023 to May 2024